Innovac Therapeutics Completes $18 million Series Pre-A Financing To Fund the Development of Its lead Programs and Manufacturing Capabilities
The funding represents a strong endorsement of Innovac’s technology, mission and vision from a range of industry Investors BOSTON, SHANGHAI and HANGZHOU, China, Sept. 1, 2023 /PRNewswire/ — Innovac Therapeutics, an mRNA therapeutics company, today announced the completion of an $18…
Comments Off on Innovac Therapeutics Completes $18 million Series Pre-A Financing To Fund the Development of Its lead Programs and Manufacturing Capabilities